Literature DB >> 6333216

Effect of selective ultraviolet phototherapy on DNA and antinuclear antibody titers in psoriatic patients.

B Leipold, H Grimm, H J Vogt, W Remy.   

Abstract

The sera of 21 psoriatics treated by selective ultraviolet phototherapy (SUP) for 1-7 months were screened for IgG- and IgM-anti-DNA antibodies and antinuclear antibodies (ANAs) by standardized ELISA and the indirect immunofluorescence technique. No patients developed IgG-antibodies against native DNA under SUP, but two patients increased their IgM-antibody titers five- and tenfold, respectively. The IgG- and IgM-anti-single-stranded-(ss)DNA antibody titers remained unaltered in 38% and 57% of the patients. In 43% and 24%, respectively, they rose to a maximum of three times their original; and in 20% they decreased to a minimum of 40% of their pretherapeutic titers. After 1 month therapy no patient had produced ANAs, but all three patients showing ANAs before therapy had increased titers (one titer step). These remained on the elevated level or were even further increased by one-titer step during progressive therapy. Two patients out of 14 developed low titers of IgM-(1:20) or IgA-(1:40)ANAs against deoxyribonucleoprotein (DNP), initially after 3 months of irradiation; in one of them IgG-ANAs (titer 1:10) against DNP were additionally formed after 6 months of therapy. Our results suggest that lesions in DNA and DNP generated by SUP trigger an immune response to nuclear antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333216     DOI: 10.1007/bf00404621

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  14 in total

1.  [Analytic differentiation of ribo- and thymo-nucleic acids].

Authors:  M PESEZ
Journal:  Bull Soc Chim Biol (Paris)       Date:  1950

Review 2.  Antinuclear antibodies.

Authors:  L L Lorincz; K Soltani; J E Bernstein
Journal:  Int J Dermatol       Date:  1981 Jul-Aug       Impact factor: 2.736

3.  Antinuclear antibodies during Puva therapy.

Authors:  M Bjellerup; M Bruze; A Forsgren; G Krook; B Ljunggren
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

4.  [Selected ultraviolet phototherapy (SUP) with fluorescent bulbs in psoriasis vulgaris. II. Effect on immune complexes, DNA antibodies and T cells in vivo].

Authors:  H Meffert; N Sönnichsen; D Metz; W Diezel
Journal:  Dermatol Monatsschr       Date:  1983-02

5.  A comparison of the Farr technique with equilibrium dialysis for measurement of antibody concentration and affinity.

Authors:  Y T Kim; S Kalver; G W Siskind
Journal:  J Immunol Methods       Date:  1975-02       Impact factor: 2.303

6.  Measurement of ultraviolet light-induced photolesions in mammalian DNA by microELISA.

Authors:  B Leipold; W Remy; B Adelmann-Grill
Journal:  J Immunol Methods       Date:  1983-05-27       Impact factor: 2.303

7.  Long-term photochemotherapy: histopathological and immunofluorescence observations in 243 patients.

Authors:  F Gschnait; K Wolff; H Hönigsmann; G Stingl; W Brenner; E Jaschke; K Konrad
Journal:  Br J Dermatol       Date:  1980-07       Impact factor: 9.302

8.  [Immunologic aspects of aging].

Authors:  R L Walford
Journal:  Klin Wochenschr       Date:  1969-06-01

9.  Is UVB treatment of psoriasis safe? A study of extensively UVB-treated psoriasis patients compared with a matched control group.

Authors:  O Larkö; G Swanbeck
Journal:  Acta Derm Venereol       Date:  1982       Impact factor: 4.437

10.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

View more
  1 in total

1.  PUVA treatment of human cultured fibroblasts from psoriatic skin enhances the binding of antibodies to SSA(Ro).

Authors:  U Wollina; H Beensen; L Kittler; H Schaarschmidt; B Knopf
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.